knowledge -WSS

knowledge

author：explore 2025-10-02 12:32:28 - browse：38

ASH19 CAR-T — Victor Segura Ibarra and Rita Serda, Ph.D., NCI, NIH

The Food and Drug Administration on Wednesday approved a futuristic new approach to treating cancer, clearing a Novartis therapy that has produced unprecedented results in patients with a rare and deadly cancer. The price tag: $475,000 for a course of treatment.

That sounds staggering to many patients — but it’s far less than analysts expected.

The therapy, called a CAR-T, is made by harvesting patients’ white blood cells and rewiring them to home in on tumors. Novartis’s product is the first CAR-T therapy to come before the FDA, leading a pack of novel treatments that promise to change the standard of care for certain aggressive blood cancers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Sen. Paul opposes bill to ban Chinese biotechs

explore

WSS

Hospital at home shows how to bring innovation to health care

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Abortion policy in the spotlight at Republican debate

How the first Native Hawaiian psychiatrist helped diversify medicine

hotspot

knowledge

entertainment

Jerome Adams on the need for new antivirals for Covid

Listen: Vivek Ramaswamy's star turn & leaky drug data

How one medical school became remarkably diverse

Listen: Vivek Ramaswamy's star turn & leaky drug data

Tori Bowie and the unacceptable rates of Black maternal death

Can U.S. cancer drug shortages be fixed?

Psychedelics group wrestles with new pharma identity

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Hollywood unions extend contract negotiations for actors

With psoriasis trial ahead, Alumis raises $259 million

focus

Kellogg’s is going to war over Mexico’s nutrition label rules

Change Healthcare payments predicted restored March 15

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

How the first Native Hawaiian psychiatrist helped diversify medicine

How the drug

leisure time

explore

Wikipedia

Wikipedia